Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q1 2025 to Q2 2025
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 7
- Est. +$13.7M
- Added
- 16
- Est. +$4.38M
- Reduced
- 19
- Est. −$10.2M
- Sold out
- 9
- Est. −$10.8M
Portfolio value went from $86.9M to $89.5M (+$2.59M (+3.0%)); positions from 45 to 43 (−2).
All Q2 2025 holdingsAll Q1 2025 holdings
In the shares, value and % of portfolio columns, the top figure is Q2 2025 and the gray one below is Q1 2025. For stocks that split between the two quarters, Q1 2025 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| SPDR Series Trust78468R796 | Sold out– | 0203,859 | −203,859−100.0% | $0$9.33M | −$9.33M | 0.0%10.7% | −10.73 |
| PIMCO ETF Tr72201R304 | Sold out– | 07,394 | −7,394−100.0% | $0$405.0K | −$405.0K | 0.0%0.5% | −0.47 |
| LEGNLegend Biotech Corp | Sold outHistory | 06,429 | −6,429−100.0% | $0$218.6K | −$218.6K | 0.0%0.3% | −0.25 |
| DJPBarclays Bank PLC | Sold outHistory | 06,120 | −6,120−100.0% | $0$216.0K | −$216.0K | 0.0%0.2% | −0.25 |
| iShares Tr464287440 | Sold out– | 02,196 | −2,196−100.0% | $0$209.0K | −$209.0K | 0.0%0.2% | −0.24 |
| Invesco Exch Traded FD Tr II46138G508 | Sold out– | 09,786 | −9,786−100.0% | $0$203.0K | −$203.0K | 0.0%0.2% | −0.23 |
| COGTCogent Biosciences, Inc. | Sold outHistory | 014,015 | −14,015−100.0% | $0$83.5K | −$83.5K | 0.0%0.1% | −0.10 |
| IMTXImmatics N.V. | Sold outHistory | 015,971 | −15,971−100.0% | $0$71.8K | −$71.8K | 0.0%0.1% | −0.08 |
| ITOSiTeos Therapeutics, Inc. | Sold outHistory | 011,061 | −11,061−100.0% | $0$66.4K | −$66.4K | 0.0%0.1% | −0.08 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.